Patent details

Basic Information

Publication number:

EP2915800

PCT Application Number:

BR2013000455

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138505177

PCT Publication Number:

WO2014066967

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INGENOL-DERIVED COMPOUNDS THAT CAN BE USED FOR TREATING CANCER

French Title of Invention:

COMPOSÉS DÉRIVÉS D'INGÉNOL UTILES DANS LE TRAITEMENT DU CANCER

German Title of Invention:

VERBINDUNGEN AUS INGENOL ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

31/10/2013

Grant date:

28/02/2018

EP Publication Date:

09/09/2015

PCT Publication Date:

08/05/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/02/2018

EP B1 Publication Date:

28/02/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/10/2018

Expiration date:

31/10/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/02/2018

 

 

Name:

Amazonia Fitomedicamentos Ltda

Address:

Rua Francisco Leandro nº 399B sala 01, CEP 60844-150-Fortaleza-CE, Brazil (BR)

Inventor

1

Name:

PIANOWSKI, Luiz Francisco

Address:

Brazil (BR)

2

Name:

TELLES, Everardo Ferreira

Address:

Brazil (BR)

Priority

Priority Number:

102012028120

Priority Date:

01/11/2012

Priority Country:

Brazil (BR)

Classification

IPC classification:

A61K 31/216; A61K 31/22; A61K 31/23; A61K 31/231; A61K 45/06; A61P 35/00; A61P 35/02; C07C 69/618; C07C 69/74;

Publication

European Patent Bulletin

Issue number:

201809

Publication date:

28/02/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1